Drug Approval Package
Iprivask (Desirudin) Injection
Company: Aventis Pharmaceuticals, Inc.
Application No.: 021271
Approval Date: 4/04/2003
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Chemistry Review(s) (PDF)
-
Environmental Assessment (PDF)
-
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
-
Administrative Document(s) & Correspondence
Part 1 (PDF)
Part 2 (PDF)
Date created: November 152004
Note: Documents in PDF format require the Adobe Acrobat Reader®.